Randomized Trial of Lifestyle Modification and Pharmacotherapy for Obesity

Top Cited Papers

17 November 2005

journal article
research article
Published by Massachusetts Medical Society in New England Journal of Medicine

Vol. 353 (20) , 2111-2120
https://doi.org/10.1056/nejmoa050156

Abstract

Weight-loss medications are recommended as an adjunct to a comprehensive program of diet, exercise, and behavior therapy but are typically prescribed with minimal or no lifestyle modification. This practice is likely to limit therapeutic benefits.

Keywords

This publication has 24 references indexed in Scilit:

Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies
Diabetes Care, 2004
Short-term effects of sibutramine (ReductilTM) on appetite and eating behaviour and the long-term therapeutic outcome
International Journal of Obesity, 2003
Combining Behavioral and Pharmacological Treatments for Obesity
Obesity Research, 2002
Obesity
New England Journal of Medicine, 2002
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
The Lancet, 2000
BEHAVIORAL TREATMENT OF OBESITY
Medical Clinics of North America, 2000
Executive Summary
Obesity Research, 1998
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
Published by Elsevier ,1998
A Double‐Blind Randomized Placebo‐Controlled Trial of Sibutramine
Obesity Research, 1996
Behavior Therapy and Pharmacotherapy for Obesity
Archives of General Psychiatry, 1981